18 January 2022 2 Min Read
Local lab gets green light to produce active ingredients derived from cannabis
GESlabs will export pharmaceutical ingredients to the UK, US, Israel and Australia where demand is high for the single molecule cannabinoids
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In